Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhou, Lisa
NCT05462873: A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors	Active, not recruiting	1	30	Europe, Japan, US, RoW	QEQ278	Novartis Pharmaceuticals	Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck	02/25	02/25
NCT05838768: Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.	Recruiting	1	327	Europe, Japan, US, RoW	HRO761, pembrolizumab, irinotecan	Novartis Pharmaceuticals	MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers	05/29	05/29
RESCUE3, NCT03783884: A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation	Terminated	N/A	223	Europe, US	Lungpacer Diaphragm Pacing Therapy, Lungpacer DPTS, AeroPace System	Lungpacer Medical Inc.	Ventilator Induced Diaphragm Dysfunction	12/22	01/23